(Q54900170)

English

KMS-18

cell line

KMS18
Kawasaki Medical School-18

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.

1 reference

Cellosaurus release 49

14 July 2024

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia

1 reference

Cellosaurus release 49

14 July 2024

Characterization of the t(4;14)(p16.3;q32) in the KMS-18 multiple myeloma cell line.

1 reference

Cellosaurus release 49

14 July 2024

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma

1 reference

Cellosaurus release 49

14 July 2024

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy

1 reference

Cellosaurus release 49

14 July 2024

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

1 reference

Cellosaurus release 49

14 July 2024

Characterization of MYC translocations in multiple myeloma cell lines

1 reference

Cellosaurus release 49

14 July 2024

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma

1 reference

Cellosaurus release 49

14 July 2024

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

1 reference

Cellosaurus release 49

14 July 2024

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

Cellosaurus release 49

14 July 2024

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

1 reference

Cellosaurus release 49

14 July 2024

Identification of novel fusion genes with 28S ribosomal DNA in hematologic malignancies

1 reference

Cellosaurus release 49

14 July 2024

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 49

14 July 2024

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 49

14 July 2024

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

multiple myeloma

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54900170&oldid=2203810174"